Drug Type Small molecule drug |
Synonyms 2-(benzo[d]thiazol-2-ylmethylthio)-6-ethoxybenzo[d]thiazole |
Target |
Mechanism AMPK modulators(AMP activated protein kinase modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus | Preclinical | IL | 26 Jun 2013 |